Product information and research
CJC-1295 / Ipamorelin
Two growth-hormone signals, one vial
Two peptides in one vial, both acting on the body's own growth-hormone signalling from different angles. The CJC-1295 in this blend is the no-DAC form, so it works over a shorter window.
Form: 5 mg + 5 mg · 3 mL vial · lyophilized
Commonly used for
- Sleep quality and recovery goals
- Body-composition conversations
- Paired protocols
What the research covers
Each ingredient has its own studies — short human hormone studies for CJC-1295, animal pharmacology for ipamorelin. The combination itself has not been studied as a blend.
Questions to ask your provider
- This blend uses the no-DAC form of CJC-1295 — what does that mean for timing?
- How would we monitor anything hormone-related?
Educational information only — not medical advice. Eligibility and treatment decisions are made by a licensed medical provider. Results vary and are not guaranteed.
Compounded medications are not FDA-approved or evaluated by FDA for safety, effectiveness, or quality.
CJC-1295 (with DAC)
Long-acting growth-hormone signal
A growth-hormone-releasing peptide built to stay in the body longer. "DAC" is the modification that extends how long it lasts.
Form: 5 mg · 3 mL vial · lyophilized
Commonly used for
- Longer-interval protocols
- Recovery and sleep goals
What the research covers
Two small randomised placebo-controlled studies in healthy adults measured growth hormone and IGF-I responses over a short period. They measured hormones, not long-term outcomes.
Questions to ask your provider
- Is the with-DAC or without-DAC form the one being discussed?
- What baseline labs make sense first?
Educational information only — not medical advice. Eligibility and treatment decisions are made by a licensed medical provider. Results vary and are not guaranteed.
Compounded medications are not FDA-approved or evaluated by FDA for safety, effectiveness, or quality.
CJC-1295 (without DAC)
Short-acting growth-hormone signal
The same family as CJC-1295 with DAC, without the modification that extends its duration — so it acts over a shorter window.
Form: 5 mg · 3 mL vial · lyophilized
Commonly used for
- Shorter-interval protocols
- Pairing with other signals
What the research covers
The published CJC-1295 human study used the long-acting form. This shorter-acting version does not have a matching human study of its own.
Questions to ask your provider
- Why this form rather than the with-DAC form?
- What would we watch over the first few weeks?
Educational information only — not medical advice. Eligibility and treatment decisions are made by a licensed medical provider. Results vary and are not guaranteed.
Compounded medications are not FDA-approved or evaluated by FDA for safety, effectiveness, or quality.
